The value of neopterin and procalcitonin in patients with sepsis

Southern Medical Journal

Volumn 103, Issue 3, 2010, Pages 216-219

  Fisgin, Nuriye Tasdelen ^a   Aliyazicioglu, Yuksel ^a   Tanyel, Esra ^a   Coban, Ahmet Yilmaz ^a   Ulger, Fatma ^a   Zivalioglu, Muammer ^a   Esen, Saban ^a   Leblebicioglu, Hakan ^a  

^a NONE

Author keywords

Neopterin; Procalcitonin; Sepsis

Indexed keywords

NEOPTERIN; PROCALCITONIN;

ADOLESCENT; ADULT; AGED; APACHE; ARTICLE; BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SCHOOL CHILD; SEPSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CALCITONIN; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPTERIN; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; SEPSIS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 77949392095     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e3181cf11a1     Document Type: Article

References (27)

1. Ruokonen E, Ilkka L, Niskanen M, et al. Procalcitonin and neopterin as indicators of infection in critically ill patients. Acta Anaesthesiol Scand 2002;46:398-404.
2. de Werra I, Jaccard C, Corradin SB, et al. Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 1997;25:607-613.
3. Adamik B, Kübler-Kielb J, Golebiowska B, et al. Effect of sepsis and cardiac surgery with cardiopulmonary bypass on plasma level of nitric oxide metabolites, neopterin, and procalcitonin: correlation with mortality and postoperative complications. Intensive Care Med 2000;26:1259-1267.
4. Strohmaier W, Redl H, Schlag G, et al. D-erythro-neopterin plasma levels in intensive care patients with and without septic complications. Crit Care Med 1987;15:757-760.
5. Nathan CF. Secretory products of macrophages. J Clin Invest 1987;79: 319-326.
6. Burleson DG, Johnson A, Salin M, et al. Identification of neopterin as a potential indicator of infection in burned patients. Proc Soc Exp Biol Med 1992;199:305-310.
7. Balogh D, Lammer H, Kornberger E, et al. Neopterin plasma levels in burn patients. Burns 1992;18:185-188.
8. Yoshida Y, Une F, Utatsu Y, et al. Adenosine and neopterin levels in cerebrospinal fluid of patients with neurological disorders. Intern Med 1999;38:133-139.
9. Le Moullec JM, Jullienne A, Chenais J, et al. The complete sequence of human preprocalcitonin. FEBS Lett 1984;167:93-97.
10. Schröder J, Staubach KH, Zabel P, et al. Procalcitonin as a marker of severity in septic shock. Langenbecks Arch Surg 1999;384:33-38.
11. Dandona P, Nix D, Wilson MF, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994;79: 1605-1608.
12. Whang KT, Vath SD, Becker KL, et al. Procalcitonin and proinflammatory cytokine interactions in sepsis. Shock 2000;14:73-78.
13. Claeys R, Vinken S, Spapen H, et al. Plasma procalcitonin and C-reactive protein in acute septic shock: clinical and biological correlates. Crit Care Med 2002;30:757-762.
14. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101: 1644-1655.
15. Muller Kobold AC, Tulleken JE, Zijlstra JG, et al. Leukocyte activation in sepsis; correlations with disease state and mortality. Intensive Care Med 2000;26:883-892.
16. Bone RC. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann Intern Med 1996;125:680-687.
17. Gérard Y, Hober D, Petitjean S, et al. High serum procalcitonin level in a 4-year-old liver transplant recipient with a disseminated candidiasis. Infection 1995;23:310-311.
18. Davis TM, Assicot M, Bohuon C, et al. Serum procalcitonin concentrations in acute malaria. Trans R Soc Trop Med Hyg 1994;88:670-671.
19. Oberhoffer M, Vogelsang H, Russwurm S, et al. Outcome prediction by traditional and new markers of inflammation in patients with sepsis. Clin Chem Lab Med 1999;37:363-368.
20. Huber C, Fuchs D, Hausen A, et al. Pteridines as a new marker to detect human T cells activated by allogeneic or modified self major histocompatibility complex (MHC) determinants. J Immunol 1983;130:1047-1050.
21. Faist E, Storck M, Hültner L, et al. Functional analysis of monocyte activity through synthesis patterns of proinflammatory cytokines and neopterin in patients in surgical intensive care. Surgery 1992;112:562-572.
22. Roumen RM, Redl H, Schlag G, et al. Inflammatory mediators in relation to the development of multiple organ failure in patients after severe blunt trauma. Crit Care Med 1995;23:474-480.
23. Gómez-Jiménez J, Martín MC, Sauri R, et al. Interleukin-10 and the monocyte/macrophage-induced inflammatory response in septic shock. J Infect Dis 1995;171:472-475.
24. Hotchkiss RS, Swanson PE, Freeman BD, et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 1999;27:1230-1251.
25. Godai K, Uemasu J, Kawasaki H. Clinical significance of serum and urinary neopterins in patients with chronic renal disease. Clin Nephrol 1991;36:141-146.
26. Delogu G, Casula MA, Mancini P, et al. Serum neopterin and soluble interleukin-2 receptor for prediction of a shock state in gram-negative sepsis. J Crit Care 1995;10:64-71.
27. Brunkhorst FM, Eberhard OK, Brunkhorst R. Discrimination of infectious and noninfectious causes of early acute respiratory distress syndrome by procalcitonin. Crit Care Med 1999;27:2172-2176.